Novartis | NOVN - Capitalización De Mercado

Precio De Mercado
121.76
Cambio Diario
-0.42 -0.34%
Mensual
0.76%
Anual
37.21%
Q2 Expectativa
119.13




Capitalización De Mercado Cambio Fecha
AbbVie USD 403.83B 5.2B 2025-12
Alcon AG USD 31.08B 1.97B 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Fresenius EUR 27.59B 889.91M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
Galapagos EUR 1.85B 76.44M 2025-12
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
J&J USD 500.24B 67.44B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 53.3B 5.72B 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novartis USD 263.08B 17.01B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Orion EUR 8.94B 243.74M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Philips EUR 22.38B 192.58M 2025-12
Recordati EUR 10.15B 660.84M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
UCB EUR 46.41B 13.94B 2025-12